Health Care: Drugs

Immunogen Inc (IMGN: NASDAQ)

$6.34 0.68 | 12.01%
07/24/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 5.66
52 Week High 8.04
52 Week Low 1.51
Avg. Daily Vol. (Mil) 2.74
Beta (3 year) 2.69
Share Related Items
Mkt Cap (Mil) 505.71
Shares Out (Mil) 89.35
Float (Mil) 71.04
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.30
Current Ratio 3.50
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 23.51
Price/Book 0.00
Price/Cash Flow -6.40
Per Share Data
Earnings -0.91
Sales 0.24
Book Value 0.00
Cash Flow -0.88
Business Summary
Immunogen Inc is a clinical-stage biotechnology company that develops targeted anticancer therapeutics. It has developed its ADC technology to enable the creation of anticancer products.
General Information
830 Winter Street
Waltham, MA 02451
Industry : Drugs
Sector: Health Care
Employees: 308
CEO: Mr. Mark J. Enyedy
Short Interest
Current Month (Mil) 15.79
Previous Month (Mil) 14.10
Short Interest Ratio (Days) 5.30
Management Effectiveness
Return on Equity n.a.
Return on Assets 0.00
Return on Investments n.a.
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with IMGN

Latest IMGN Headlines from TheStreet

More Financial News for IMGN

Press Releases for IMGN

See All Press Releases

Partner Headlines for IMGN

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter